Diagnostic Value of Serum Alpha-L-Fucosidase in Detecting Hepatocellular Carcinoma in Cirrhotic Patient

Background: Tumour markers are pivotal tools for the early diagnosis of tumours. Alpha Fetoprotein (AFP) is a major marker widely used for the detection of hepatocellular carcinoma (HCC). However, AFP shows poor sensitivity and specificity in the early stages of HCC. Moreover AFP levels are not elevated in some HCC patients, while they are elevated in other patients with benign liver disease. New biomarkers are urgently needed for specific early diagnosis of HCC patients. Alpha- L- Fucosidase (AFU), a lysosomal enzyme present in all mammalian cells, has been proposed as a tumour marker since many studies reported increased AFU serum levels in patients with cirrhosis with HCC patients. Objectives: This study aimed to evaluate the diagnostic value of AFU in detecting of HCC. Methods: This cross-sectional observational study was conducted in the Department of Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka during the period from December 2019 to August 2020. Thirty three HCC patients with cirrhosis and 33 patients with liver cirrhosis were included. All HCC patients underwent FNA for cytopathological examination. Serum AFU levels were measured by enzyme-linked immunosorbent assay (ELISA) method and compared. Data were processed and analyzed with the help of computer program SPSS (Statistical Package for the Social Sciences) 25 version. Quantitative data were analyzed by mean and standard deviation; and comparison was done between two groups by unpaired t test or Mann-Whitney U test. Qualitative data were analyzed by frequency and percentage; and comparison was done between two groups by Chi- Square (χ2) test or Fisher' s Exact Test. A statistically significant result has been considered when p value less than 0.05. Results: The study revealed significant differences in serum Alpha-L-Fucosidase (AFU) and Alpha-Fetoprotein (AFP) levels between hepatocellular carcinoma (HCC) and cirrhosis groups. The median AFU levels were significantly ...

Authors

Institutions

Publication Details

Journal
Scholars Journal of Applied Medical Sciences
Published
2024-12-10
DOI
https://doi.org/10.36347/sjams.2024.v12i12.014
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic Value of Serum Alpha-L-Fucosidase in Detecting Hepatocellular Carcinoma in Cirrhotic Patient

Dewan S Alam, Mohoshina Karim, Arifa Tasnim, Nooruddin Ahmad et al.
Scholars Journal of Applied Medical Sciences
Liver Disease Diagnosis and Treatment
article

Diagnostic Value of Serum Alpha-L-Fucosidase in Detecting Hepatocellular Carcinoma in Cirrhotic Patient

Dewan S Alam, Mohoshina Karim, Arifa Tasnim, Nooruddin Ahmad, Asma Helen Khan, Dr. Md. Shayedul Ashik
article en

Abstract

Background: Tumour markers are pivotal tools for the early diagnosis of tumours. Alpha Fetoprotein (AFP) is a major marker widely used for the detection of hepatocellular carcinoma (HCC). However, AFP shows poor sensitivity and specificity in the early stages of HCC. Moreover AFP levels are not elevated in some HCC patients, while they are elevated in other patients with benign liver disease. New biomarkers are urgently needed for specific early diagnosis of HCC patients. Alpha- L- Fucosidase (AFU), a lysosomal enzyme present in all mammalian cells, has been proposed as a tumour marker since many studies reported increased AFU serum levels in patients with cirrhosis with HCC patients. Objectives: This study aimed to evaluate the diagnostic value of AFU in detecting of HCC. Methods: This cross-sectional observational study was conducted in the Department of Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka during the period from December 2019 to August 2020. Thirty three HCC patients with cirrhosis and 33 patients with liver cirrhosis were included. All HCC patients underwent FNA for cytopathological examination. Serum AFU levels were measured by enzyme-linked immunosorbent assay (ELISA) method and compared. Data were processed and analyzed with the help of computer program SPSS (Statistical Package for the Social Sciences) 25 version. Quantitative data were analyzed by mean and standard deviation; and comparison was done between two groups by unpaired t test or Mann-Whitney U test. Qualitative data were analyzed by frequency and percentage; and comparison was done between two groups by Chi- Square (χ2) test or Fisher' s Exact Test. A statistically significant result has been considered when p value less than 0.05. Results: The study revealed significant differences in serum Alpha-L-Fucosidase (AFU) and Alpha-Fetoprotein (AFP) levels between hepatocellular carcinoma (HCC) and cirrhosis groups. The median AFU levels were significantly ...

Scholars Journal of Applied Medical SciencesVol. 12(12)
Bangladesh Medical University (BD), National Institute of Cardiovascular Diseases (BD), Directorate General of Health Services (BD)
No poverty
Openalex Percentile: Top 65%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.